Plant Impact is making significant progress on route to commercialization

Plant Impact is making significant progress on the route to commercialization, according to independent company research specialists Equity Development.

Denis Gross, Equity development analyst, beleives that Plant Impact will be able to accelerate its commercialisation timeline, with the help of its three well chosen strategic partners - Arysta LifeScience, Agrimatco and Cebeco.

The company is developing new types of crop protection products. Its products provide ‘stress relief’ to plants, in the sense that they tackle abiotic stress - negative environmental effects - arising from temperature, salinity, drought and light.

So far Plant Impact has developed five technologies, with associated patents, and a broad range of high quality products that it believes represent the future of sustainable agriculture and food production.

One of the key drivers of the Plant Impact story are the many ongoing field trials that are testing its products on a variety of crops in many different environments – including the Netherlands, the UK and Kenya.

In his note to investors Denis Gross highlighted Plant Impact’s success with the trials, particularly the study of InCa’s - a calcium delivery system - effect on potato crop yields.

"Trial results to date continue to be very encouraging,” Gross adds: “These trials showed that: InCa increased marketable yield; improved the overall quality of the potatoes; and enhanced storage and shelf life.”

The analyst, using a conservative discounted cash flow model (with a 20 percent discount rate and a 1 percent long-term growth rate), values Plant Impact a 58 pence per share.